HopeStage
Back to all studies
CompletedNCT03113890

Pharmacogenetic Testing and Treatment Outcomes in Psychiatric Inpatients

About this titleRead the official source — NCT03113890
Interventional studyAges 18+United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
BelmontSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: September 22, 2017
Recruitment status
Completed
Enrollment listed in the registry
75
Sponsor
Mclean Hospital
Sponsor type
Hospital / academic medical center
Study type
Other
Intervention type
Genetic, Other
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT03113890
Official title
Show the full official title

McLean and Genomind Prospective Study of Pharmacogenetic Testing

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Belmont

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Mclean Hospital, a hospital or academic medical center.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies